ARTICLES BY THIS AUTHOR
- 12/12/2021
Hy-Vee names new COO, elevates executives
After announcing the retirement of two executives, the company shared that Jeremy Gosch has been appointed president and chief operating officer. - 12/12/2021
Walmart to use Inovalon’s Data Insights Solution
Inovalon's Data Insights Solution is intended to enable acceleration to a more patient-centric healthcare model. - 12/9/2021
Kroger to open customer fulfillment center in North Carolina
The North Carolina customer fulfillment center, expected to become operational within 24 months, will employ up to 700 associates over the next five years. - 12/9/2021
Pfizer-BioNTech’s COVID-19 booster shot approved for ages 16 and 17 years old
The Food and Drug Administration amended the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine, authorizing the use of a single booster dose for administration to individuals aged 16 and 17 years old. - 12/9/2021
Richter, Hikma ink deal for proposed biosimilars Prolia, Xgeva
Prolia and Xgeva are used to treat osteoporosis and fractures due to bone metastasis respectively. - 12/8/2021
CVS Health to capitalize on opportunities to make health care convenient
CVS Health noted that advancement of health services and primary care capabilities will augment performance in foundational businesses while creating new opportunities in high-growth markets. - 12/8/2021
Dr. Reddy's intros generic Diovan
Dr. Reddy’s valsartan tablets are indicated to lower high blood pressure and hypertension in adults and children between the ages of 1 to 16 years old. - 12/8/2021
AstraZeneca given FDA approval for Evusheld
Evusheld, packaged with cilgavimab and administered together, is used for the prevention of COVID-19 in certain adults and pediatric individuals. - 12/5/2021
VBI Vaccines obtains FDA OK for PreHevbrio
PreHevbrio is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years old and older. - 12/5/2021
NACDS, HPP report highlights role pharmacies play during health emergencies
The third in a series of NACDS reports shows how valuable experiences and lessons learned during the COVID pandemic response can help inform policy decisions and future pandemic planning and preparedness.